P53: At the crossroads of molecular carcinogenesis and molecular epidemiology

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 2, 1996, Pages 115-118

  Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENETIC PREDISPOSITION; GENETICS; HUMAN; MUTATION; NEOPLASM; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NEOPLASMS;

EID: 0030112274     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Aguilar F, Hussain SP, Cerutti P: Aflatoxin Dl induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90:8586-8590. 1993
2. Barrctt JC, Viscman RW: Molecular carcinogcnesis in humans and rodents. Prog Clin Biol Res 376:1-30, 1992
3. Bishop JM: Molecular themes in oncogcnesis. Cell 64:235-248, 1991
4. Bito T, Ueda M, Ahmed NU, Nagano T, Ichihashi M: Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression. J Ciiian Pathol 22:427-434, 1995
5. Bohr VA: Gene specific DNA repair. Camnomesis 12:1983-1992, 1991
6. Borkowski A, Bennett WP, Jones RT, Borkowski P, Harris CC, Ferreira LR, Kao GF, Trump BF: Quantitative image analysis of p53 protein accumulation in keratoacanthomas. AmJ Dermatopatlwl 17:335-338, 1996
7. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Nail Acad Sci USA 88:10124-10128, 1991
8. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431, 1991
9. Buratowski S: DNA repair and transcription: the helicase connection. Stietice 260:37-38, 1993
10. Chen RH, Maher VM, Brouwer J, van de Putte P, McCormickJJ: Preferential repair and strand-specific repair of benzo[a]pyrene diol cpoxide adducts in the HPRT gene of diploid human fibroblasts. Proc \'atl Acad Sci USA 89:5413-5417, 1992
11. Clio Y, Gorina S, Jetfrey P, Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: a framework for understanding how mutations inactivate p53. Science 265:346-355, 1994
12. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Katun 362:849-852, 1993
13. Dittmer D, Pad S, Zambetti G, Chu S, Tercsky AK, Moore M, Finlay C, Levine AJ: Gain of function mutations in p53. Nature Genet 4:42-46, 1993
14. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butcl JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221, 1992
15. Evans MK, Taffe BG, Harris CC, Bohr VA: DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts. Canter Res 53:5377-5381, 1993
16. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994
17. Harris CC: Chemical and physical carcinogenesis: advances and perspectives. Cancer Res 51:5023s-5044s, 1991
18. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engt] Mcd 329:1318-1327, 1993
19. Hartwell L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546, 1992
20. Herman JG, tarif F, Weng Y, Lcrman MI, Zbar D, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, Baylin SB: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Nail Acad Sci USA 91:9700-9704, 1994
21. Hollstein M, Sidransky D, Vogelstein B, Harris CG: p53 Mutations in human cancers. Science 253:49-53, 1991
22. Hsu 1C, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CG: Mutational hotspot in the p53 gcne in human hcpatocellular carcinomas. Kahm 350:427-428, 1991
23. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace A Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597, 1992
24. Kerschmann RL, McCalmont TH, LeBoit PE: p53 Oncoprotcin expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 130:181-186, 1994
25. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823, 1971
26. Lane DP, Benchimol S: p53: oncogene or anti-oncogene. Gcties Dev 4:1-8, 1990
27. Lavigueur A, Maltby V, Mock D, Rossant J, Pa\vson T, Bernstein A: High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982-3991, 1989
28. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453-456, 1991
29. Livingstone LR, Wliite A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935, 1992
30. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 Is required for radiation-induced apoptosis in mouse thymocytcs. Nature 362:847-849, 1993
31. Malkin D, Li FP, Strong LC, Fraumcni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsfcy MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990
32. Nagano T, Ueda M, Ichihashi M: Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dertnatol 129:1157-1161, 1993
33. National Research Council: Assessment of toxicology. In: National Academy of Sciences (ed.). ScieiKe and Judgement in Risk Assessment. National Academy Press, Washington, DC, 1994, pp 56-67
34. Nguyen T, Brunson D, Crespi CL, Penman BW, WisIinokJS, Tannenbaum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Biochemistry 285:1173-1180, 1992
35. Ponchel F, Puisieux A, Tabone E, Michot JP, Froschl G, Morel AP, Frebourg T, Fontaniere B, Oberhammer F, Ozturk M: Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res 54:2064-2068, 1994
36. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK: p53 Mutations in basal cell carcinomas. Cancer Res 52:3804-3806, 1992
37. Rideout WM 3d, Coetzee GA, Olumi AF, Jones PA: 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249:1288-1290, 1990
38. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Hamik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanai O, Lavin MF, Jaspers NG, Malcolm A, Taylor R, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single ataxia-telangiectasia gene with a product similar to Pi-3 kinase. Science 268:1749-1753, 1995
39. Schaeffer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH, Chambon P, EglyJM: DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260:58-63, 1993
40. Selby CP, Sancar A: Molecular mechanism of transcription-repair coupling. Scieixe 260:53-58, 1993
41. Shen JC, Rideout WM, Jones PA: High frequency mutagenesis by a DNA methyltransferase. Cell 71:1073-1080, 1992
42. Stephenson TJ, Royds J, Silcocks PB, Blechen SS: Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma [see comments]. Dr J Dcrmatol 127:566-570, 1992
43. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai K, Mabuchi K, Land CE, Harris CC: p53 mutations in lung cancers from non-smoking atomicbomb survivors. Lancet 342:1520-1521, 1993
44. Tomaletti S, Pfeifer GP: Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263:1436-1438, 1994
45. Vogelstein B, Kinzler KW: p53 Function and dysfunction. Cell 70:523-526, 1992
46. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, EglyJM, Wang Z, Friedberg EC, Evans MK, Taffe EG, Bohr VA, Hoeijmakers JH, Forrester K, Harris CC: p53 Modulation of TFlIH-associated nucleotide excision repair activity. Nature Genet 10:188-195, 1995
47. Weinberg RA: Tumor suppressor genes. Science 254:1138-1146, 1991
48. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Alien JS, Reefer LK: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003, 1991
49. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948, 1992